SCHEMBL20437002

SCHEMBL20437002

O=C1CCC(n2cc(-c3ccc(N4CCNCC4)cc3)cn2)C(=O)N1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 11/20 0.51
DDB1 Q16531 9/20 0.51
ACVR1 Q04771 5/20 0.40
TGFBR1 P36897 4/20 0.40
KDR P35968 3/20 0.40
PRKAB1 Q9Y478 3/20 0.40
BMPR1B O00238 4/20 0.39
ACVRL1 P37023 4/20 0.39
BMPR1A P36894 3/20 0.39
ACVR1B P36896 2/20 0.39
TGFBR2 P37173 2/20 0.39
BMPR2 Q13873 2/20 0.39
ALDH1A1 P00352 1/20 0.37
CHRM2 P08172 1/20 0.37
OPRM1 P35372 1/20 0.37
IKZF3 Q9UKT9 1/20 0.37
CYP1A2 P05177 1/20 0.37
TSHR P16473 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
RET P07949 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25035121 0.86 CRBN (0.48) CRBNDDB1ALDH1A1CHRM2OPRM1
SCHEMBL20812187 0.81 CRBN (0.52) CRBNDDB1ALDH1A1CHRM2OPRM1
SCHEMBL20437001 0.80 DDB1 (0.57) CRBNDDB1ALDH1A1RET
SCHEMBL31425953 0.78 CRBN (0.46) CRBNDDB1ALDH1A1CHRM2OPRM1
SCHEMBL30769479 0.75 CRBN (0.50) CRBNDDB1ALDH1A1CHRM2OPRM1
SCHEMBL20234966 0.74 CRBN (0.52) CRBNDDB1ALDH1A1CHRM2OPRM1
SCHEMBL31612900 0.73 CRBN (0.62) CRBNDDB1ALDH1A1CHRM2OPRM1
SCHEMBL31612902 0.73 CRBN (0.62) CRBNDDB1ALDH1A1CHRM2OPRM1
SCHEMBL20423189 0.73 CRBN (0.48) CRBNDDB1ACVR1ALDH1A1CHRM2
SCHEMBL26100060 0.72 CRBN (0.58) CRBNDDB1TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183209-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME ARVINAS OPERATIONS, INC. (US) 2023-06-15 US disclosed
US-20180215731-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME ARVINAS OPERATIONS, INC. 2018-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183209-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME CRBN, CBL, MDM2 CRBN 1/4885DDB1 399/4885ACVR1 2807/4885
US-20180215731-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME CRBN, CBL, MDM2 CRBN 1/4885DDB1 399/4885ACVR1 2807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.